Edwardsiella tarda Native Valve Infective Endocarditis in a Young and Non-Immunocompromised Host: A Case Report.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
09 Oct 2021
09 Oct 2021
Historique:
entrez:
9
10
2021
pubmed:
10
10
2021
medline:
13
10
2021
Statut:
epublish
Résumé
BACKGROUND Infective endocarditis (IE) is an infectious disease that occurs in valves, centered on the endocardium and ventricular septal defects. It is a serious disease that is easily misdiagnosed and has a high mortality rate if left untreated. Edwardsiella tarda is an extremely rare cause of IE, especially in young and non-immunocompromised hosts. CASE REPORT A woman in her 20s presented to our hospital with fever of unknown cause and liver dysfunction. She was admitted to the Department of Gastroenterological Medicine owing to suspicion of gastrointestinal infection. Gastrointestinal examination, including contrast-enhanced computer tomography and endoscopic ultrasonography, was performed; however, there were no significant findings. Liver dysfunction improved spontaneously, but her fever did not improve with antibiotic treatment. Transthoracic echocardiography was performed on day 9 of hospitalization because E. tarda was detected in a blood culture test, revealing vegetation at the mitral valve. Asymptomatic cerebral infarction was shown by brain magnetic resonance imaging, and mitral valvuloplasty was performed on day 14. After surgery, transthoracic echocardiography was performed on day 22, showing no vegetation or mitral regurgitation. However, postoperative transesophageal ultrasonography performed on day 29 revealed severe mitral regurgitation. Redo mitral valvuloplasty was performed on day 38. She clinically improved and was discharged on day 67. CONCLUSIONS This is the first case in which E. tarda was diagnosed as the causative agent of IE on a native valve in a young and non-immunocompromised host. Aggressive source control resulted in a good clinical outcome.
Identifiants
pubmed: 34625525
pii: 932387
doi: 10.12659/AJCR.932387
pmc: PMC8515497
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e932387Références
Int J Clin Pract. 2005 Aug;59(8):917-21
pubmed: 16033613
J La State Med Soc. 2009 Mar-Apr;161(2):103-6
pubmed: 19489391
Eur Heart J. 2019 Oct 14;40(39):3222-3232
pubmed: 31504413
Case Rep Infect Dis. 2016;2016:1082160
pubmed: 26885418
Pediatr Transplant. 2008 Mar;12(2):238-41
pubmed: 18086238
Indian J Med Microbiol. 2012 Jul-Sep;30(3):352-4
pubmed: 22885207
Ann Intern Med. 2007 Dec 18;147(12):829-35
pubmed: 18087053
Clin Infect Dis. 1993 Oct;17(4):742-8
pubmed: 8268359
Circ J. 2013;77(6):1558-64
pubmed: 23524445
Antimicrob Agents Chemother. 2001 Aug;45(8):2245-55
pubmed: 11451681
Clin Infect Dis. 1997 Oct;25(4):918-9
pubmed: 9356809